Bookmarks
Evaluation of the effectiveness and safety of early rule out pathways for acute myocardial infarction across the United Kingdom
Safe People
Organisation name
Imperial College London
Organisation sector
Academic Institute
Applicant name(s)
Rachael Lear
Catalina Carenzo
Funders/ Sponsors
Jamil Mayet
DEA accredited researcher?
Unknown
Sub-licence arrangements (if any)?
No
Safe Projects
Project ID
NIBDAPC_2022_0019
Lay summary
Chest pain is one of the most common reasons for presentation to hospital worldwide. However, most patients attending hospital with chest pain are not experiencing a heart attack. Medical professionals need safe and effective ways to identify patients who are not having heart attacks, so that these patients are not admitted to hospital unnecessarily. This could free up beds for other patients who need to come into hospital. ‘Troponin’ is a protein that is released into the bloodstream during a heart attack. Medical professionals can test troponin levels in a patient’s blood to help diagnose - or rule out - heart attack. Troponin tests are one component of the diagnostic pathway for patients coming into the Emergency Department with chest pain. However, different hospitals are using different diagnostic pathways for patients; these pathways vary in terms of the timing of troponin tests and the thresholds that medical professional use to interpret results. At present we do not know which pathway works best to identify patients who are not suffering a heart attack. There may also be differences with regards to the outcomes of patients of different ages, sex, and ethnic groups, who experience chest pain. The aim of this project is to explore differences in chest pain pathways to understand the impacts on patient safety and hospital admission rates, including how patients use the health service after being discharged from the Emergency Department. Collaborating side by side with University Hospitals Birmingham NHS Foundation Trust, Barts Health NHS Trust and University Hospital Southampton NHS Foundation Trust, Imperial College Healthcare NHS Trust’s work is part of a national study proposed by the Health Data Research UK (HDR UK), the UK's national institute for health data science. Each Trust will conduct a local analysis of their data, then the local analyses will be combined at a national level. This work will provide new insights into why patient outcomes vary, enabling initiatives to improve the quality and safety of care delivery for patients presenting to the Emergency Department with chest pain.
Public benefit statement
This research will lead to benefits for patients attending the Emergency Department in the UK in the future. Our work will inform new ways of working in the Emergency Department to help medical professionals diagnose patients coming in with chest pain. This will mean that patients who are not suffering from a heart attack can be safely allowed to go home instead of having to stay in hospital overnight. In turn, this will free up beds for patients who do need to be admitted to hospital and could reduce the time patients spend in the Emergency Department waiting to be admitted to a ward. For patients with chest pain that is suspicious for heart attack, this work could lead to a reduction in time spent waiting for cardiac investigations or for transfer for specialist treatment.
Request category type
Public Health Research
Other approval committees
Project start date
13/03/2023
Latest approval date
25/11/2022
Safe Data
Dataset(s) name
ICHT HDR UK Myocardial Infarction Research Dataset
Data sensitivity level
De-Personalised
Common Law Duty of Confidentiality
Not applicable
National data opt-out applied?
Not applicable
Request frequency
One-off
Release/Access date
13/03/2023
Safe Setting
Access type
TRE
Safe Outputs
Link to research outputs